https://doi.org/10.1186/s13054-021-03471-2
K
Karine Santos
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
74
Papers
1.7K
Citations
24
h-index
37
i10-index
Karine Santos is an academic researcher from MerLion Pharma (Germany). The author has contributed to research in topics: RNA and protein synthesis mechanisms & RNA Research and Splicing & RNA modifications and cancer. The author has an h-index of 24, co-authored 63 publications.
ORCID: 0000-0003-0467-7708Papers by this author
worksMonitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study
2021 · Critical Care · 72 citations
Circulating dipeptidyl peptidase-3 at admission is associated with circulatory failure, acute kidney injury and death in severely ill burn patients
2020 · Critical Care · 51 citations
https://doi.org/10.1186/s13054-020-02888-5
Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury
2024 · Intensive Care Medicine Experimental · 17 citations
https://doi.org/10.1186/s40635-024-00638-3
High Circulating Dipeptidyl Peptidase 3 Predicts Mortality and Need for Organ Support in Cardiogenic Shock: An Ancillary Analysis of the ACCOST-HH Trial
2024 · Journal of Cardiac Failure · 11 citations
https://doi.org/10.1016/j.cardfail.2024.03.014
Targeting high circulating dipeptidyl peptidase 3 in circulatory failure
2025 · Critical Care · 4 citations
https://doi.org/10.1186/s13054-025-05545-x
Interplay of <i>cis</i>- and <i>trans</i>-regulatory mechanisms in the spliceosomal RNA helicase Brr2
2016 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.4251890
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat